|
1
|
Lippi G, Sanchis-Gomar F and Cervellin G:
Global epidemiology of atrial fibrillation: An increasing epidemic
and public health challenge. Int J Stroke. 16:217–221. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Scott L Jr, Li N and Dobrev D: Role of
inflammatory signaling in atrial fibrillation. Int J Cardiol.
287:195–200. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pozios I, Vouliotis AI, Dilaveris P and
Tsioufis C: Electro-mechanical alterations in atrial fibrillation:
Structural, electrical, and functional correlates. J Cardiovasc Dev
Dis. 10:1492023.PubMed/NCBI
|
|
4
|
Harada M, Van Wagoner DR and Nattel S:
Role of inflammation in atrial fibrillation pathophysiology and
management. Circ J. 79:495–502. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Harada M and Nattel S: Implications of
inflammation and fibrosis in atrial fibrillation pathophysiology.
Card Electrophysiol Clin. 13:25–35. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sygitowicz G, Maciejak-Jastrzębska A and
Sitkiewicz D: A review of the molecular mechanisms underlying
cardiac fibrosis and atrial fibrillation. J Clin Med. 10:44302021.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Noubiap JJ, Sanders P, Nattel S and Lau
DH: Biomarkers in atrial fibrillation: pathogenesis and clinical
implications. Card Electrophysiol Clin. 13:221–233. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li Y, Tan W, Ye F, Wen S, Hu R, Cai X,
Wang K and Wang Z: Inflammation as a risk factor for stroke in
atrial fibrillation: Data from a microarray data analysis. J Int
Med Res. 48:3000605209216712020.PubMed/NCBI
|
|
9
|
Liao Y, Tsai L, Lee Y, Hsieh P, Yu C and
Lu M: miR-21 promotes the fibrotic properties in oral mucosa
through targeting PDCD4. J Dent Sci. 17:677–682. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhao M, Zhu N, Hao F, Song Y, Wang Z, Ni Y
and Ding L: The regulatory role of non-coding RNAs on programmed
cell death four in inflammation and cancer. Front Oncol. 9:9192019.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nara K, Kawashima N, Noda S, Fujii M,
Hashimoto K, Tazawa K and Takashi Okiji: Anti-inflammatory roles of
microRNA 21 in lipopolysaccharide-stimulated human dental pulp
cells. J Cell Physiol. 234:21331–21341. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang J, Zhang M, Yang Z, Huang S, Wu X,
Cao L, Wang X, Li Q, Li N and Gao F: PDCD4 deficiency ameliorates
left ventricular remodeling and insulin resistance in a rat model
of type 2 diabetic cardiomyopathy. BMJ Open Diabetes Res Care.
8:e0010812020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Desai KM, Kale AD, Angadi PV, Datar UV,
Belaldavar C and Arany PR: Role of programmed cell death 4 in
myofibroblast differentiation in oral submucous fibrosis. J Oral
Maxillofac Pathol. 25:430–436. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Perveen R, Ozaki I, Manirujjaman M, Mine
K, Murata Y, Tanaka K, Xia J, Takahashi H, Anzai K and Matsuhashi
S: Induction of premature senescence and a less-fibrogenic
phenotype by programmed cell death 4 knockdown in the human hepatic
stellate cell line Lieming Xu-2. Hum Cell. 36:583–601. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Takada I and Makishima M: Peroxisome
proliferator-activated receptor agonists and antagonists: A patent
review (2014-present). Expert Opin Ther Pat. 30:1–13. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gao Z, Xu X, Li Y, Sun K, Yang M, Zhang Q,
Wang S, Lin Y, Lou L, Wu A, et al: Mechanistic insight into PPARγ
and Tregs in atherosclerotic immune inflammation. Front Pharmacol.
12:7500782021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yu H, Lin L, Zhang Z, Zhang H and Hu H:
Targeting NF-κB pathway for the therapy of diseases: Mechanism and
clinical study. Signal Transduct Target Ther. 5:2092020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Korbecki J, Bobiński R and Dutka M:
Self-regulation of the inflammatory response by peroxisome
proliferator-activated receptors. Inflamm Res. 68:443–458. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lu X, He Y, Johnston RL, Nanayakarra D,
Sankarasubramanian S, Lopez JA, Friedlander M, Kalimutho M, Hooper
JD, Raninga PV and Khanna KK: CBL0137 impairs homologous
recombination repair and sensitizes high-grade serous ovarian
carcinoma to PARP inhibitors. J Exp Clin Cancer Res. 41:3552022.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cabrera-Bueno F, Medina-Palomo C,
Ruiz-Salas A, Flores A, Rodríguez-Losada N, Barrera A,
Jiménez-Navarro M and Javier Alzueta J: Serum levels of
interleukin-2 predict the recurrence of atrial fibrillation after
pulmonary vein ablation. Cytokine. 73:74–78. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Diwan A, Dibbs Z, Nemoto S, DeFreitas G,
Carabello BA, Sivasubramanian N, Wilson EM, Spinale FG and Mann DL:
Targeted overexpression of noncleavable and secreted forms of tumor
necrosis factor provokes disparate cardiac phenotypes. Circulation.
109:262–268. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chang X, Zhang T, Wang J, Liu Y, Yan P,
Meng Q, Yin Y and Wang S: SIRT5-related desuccinylation
modification contributes to quercetin-induced protection against
heart failure and high-glucose-prompted cardiomyocytes injured
through regulation of mitochondrial quality surveillance. Oxid Med
Cell Longev. 2021:58768412021. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gao Y, Li H, Zhou Y, Lv H and Chen Y:
PDCD4 expression in coronary atherosclerosis rat models and its
mechanism. Exp Ther Med. 17:3150–3154. 2019.PubMed/NCBI
|
|
25
|
Watanabe K, Narumi T, Watanabe T, Otaki Y,
Takahashi T, Aono T, Goto J, Toshima T, Sugai T, Wanezaki M, et al:
The association between microRNA-21 and hypertension-induced
cardiac remodeling. PLoS One. 15:e02260532020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhou X, Chai H, Bai M and Zhang Z:
LncRNA-GAS5 regulates PDCD4 expression and mediates myocardial
infarction-induced cardiomyocytes apoptosis via targeting MiR-21.
Cell Cycle. 19:1363–1377. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dobrev D, Heijman J, Hiram R, Li N and
Nattel S: Inflammatory signalling in atrial cardiomyocytes: A novel
unifying principle in atrial fibrillation pathophysiology. Nat Rev
Cardiol. 20:145–167. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lu K, Chen Q, Li M, He L, Riaz F, Zhang T
and Li D: Programmed cell death factor 4 (PDCD4), a novel therapy
target for metabolic diseases besides cancer. Free Radic Biol Med.
159:150–163. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li J, Guo C and Wu J: The agonists of
peroxisome proliferator-activated receptor-γ for liver fibrosis.
Drug Des Devel Ther. 15:2619–2628. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zulueta A, Colombo M, Peli V, Falleni M,
Tosi D, Ricciardi M, Baisi A, Bulfamante G, Chiaramonte R and
Caretti A: Lung mesenchymal stem cells-derived extracellular
vesicles attenuate the inflammatory profile of cystic fibrosis
epithelial cells. Cell Signal. 51:110–118. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kökény G, Calvier L and Hansmann G: PPARγ
and TGFβ-major regulators of metabolism, inflammation, and fibrosis
in the lungs and kidneys. Int J Mol Sci. 22:104312021. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Luo J, Wang J, Zhang J, Sang A, Ye X,
Cheng Z and Li X: Nrf2 deficiency exacerbated CLP-induced pulmonary
injury and inflammation through autophagy- and NF-κB/PPARγ-mediated
macrophage polarization. Cells. 11:39272022. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sun W, Wu Y, Gao M, Tian Y, Qi P, Shen Y,
Huang L, Shi L, Wang Y and Liu X: C-reactive protein promotes
inflammation through TLR4/NF-κB/TGF-β pathway in HL-1 cells. Biosci
Rep. 39:BSR201908882019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ren KW, Yu XH, Gu YH, Xie X, Wang Y, Wang
SH, Li HH and Bi HL: Cardiac-specific knockdown of Bhlhe40
attenuates angiotensin II (Ang II)-Induced atrial fibrillation in
mice. Front Cardiovasc Med. 9:9579032022. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu H, Sun J, Gao L, Fan L, Chen D and Wu
L: MicroRNA-421 attenuates macrophage-mediated inflammation by
inhibiting PDCD4 in vitro. Mol Med Rep. 24:5272021.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liang X, Xu Z, Yuan M, Zhang Y, Zhao B,
Wang J, Zhang A and Li G: MicroRNA-16 suppresses the activation of
inflammatory macrophages in atherosclerosis by targeting PDCD4. Int
J Mol Med. 37:967–975. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhou G, Duan Y, Lu C and Wang W: Knockdown
of circ-UQCRC2 ameliorated lipopolysaccharide-induced injury in
MRC-5 cells by the miR-326/PDCD4/NF-κB pathway. Int
Immunopharmacol. 97:1076332021. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wan F and Lenardo MJ: The nuclear
signaling of NF-kappaB: Current knowledge, new insights, and future
perspectives. Cell Res. 20:24–33. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang Z, Zhang X, Meng L, Gong M, Li J,
Shi W, Qiu J, Yang Y, Zhao J, Suo Y, et al: Pioglitazone inhibits
diabetes-induced atrial mitochondrial oxidative stress and improves
mitochondrial biogenesis, dynamics, and function through the
PPAR-γ/PGC-1α signaling pathway. Front Pharmacol. 12:6583622021.
View Article : Google Scholar : PubMed/NCBI
|
